Evidence map›Paper›PMID 32605220›Full record

ReviewCells2020

Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story.

Ugo Ala

Abstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed.

  1. Review
  2. Article
  3. Epigenetic Connections in Malocclusion.International journal of molecular sciences · 2026
    Review
  4. Review
  5. TheBiology · 2026
    Article
  6. Review
  7. Article
  8. Vitamin D Reprograms Non-Coding RNA Networks to Block Zika Virus in Human Macrophages.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  9. The Evolution of Bees: Insights from 'Omic Studies.Genome biology and evolution · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Non-coding RNA · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Non-coding RNA profiling in BRAFScientific data · 2025
    Article
  19. Review
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ugo AlaDepartment of Veterinary Sciences, University of Turin, 10124 Turin, Italy.ORCID 0000-0001-5408-6397

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs), a class of small non-coding RNA molecules, are responsible for RNA silencing and post-transcriptional regulation of gene expression. They can mediate a fine-tuned crosstalk among coding and non-coding RNA molecules sharing miRNA response elements (MREs). In a suitable environment, both coding and non-coding RNA molecules can be targeted by the same miRNAs and can indirectly regulate each other by competing for them. These RNAs, otherwise known as competing endogenous RNAs (ceRNAs), lead to an additional post-transcriptional regulatory layer, where non-coding RNAs can find new significance. The miRNA-mediated interplay among different types of RNA molecules has been observed in many different contexts. The analyses of ceRNA networks in cancer and other pathologies, as well as in other physiological conditions, provide new opportunities for interpreting

Indexed as

AnimalsGene Expression Regulation, NeoplasticHumansMicroRNAsNeoplasmsNeurodegenerative DiseasesRNA, UntranslatedMicroRNAsRNA, Untranslatedcancercardiovascular pathologiesceRNA mechanismcompeting endogenous RNAsmiRNAneurodegenerative disordersnon-coding RNAs

Identifiers

PMID32605220
PMCPMC7407898

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.